Cargando…
Corrigendum: Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival
Autores principales: | Kang, Youn-Jung, Balter, Barbara, Csizmadia, Eva, Haas, Brian, Sharma, Himanshu, Bronson, Roderick, Yan, Catherine T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561539/ https://www.ncbi.nlm.nih.gov/pubmed/28805210 http://dx.doi.org/10.1038/ncomms15795 |
Ejemplares similares
-
Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival
por: Kang, Youn-Jung, et al.
Publicado: (2017) -
Corrigendum: TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer
por: Banerjee, Rajat, et al.
Publicado: (2016) -
CORRIGENDUM: The Evidence of Glioblastoma Heterogeneity
por: Soeda, Akio, et al.
Publicado: (2015) -
Corrigendum: PTEN ameliorates autoimmune arthritis through down-regulating STAT3 activation with reciprocal balance of Th17 and Tregs
por: Lee, Seung Hoon, et al.
Publicado: (2017) -
Corrigendum: A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion
por: Ikenoue, Tsuneo, et al.
Publicado: (2017)